Blinatumomab Educational Session
APPHON/ROHPPA hosted an Educational Session on:
Blinatumomab Administration for Healthcare Professionals
11 September 2024
Presented by:
Dr. Tamara MacDonald, Tracy MacNeil and Christa McGuirk
Blinatumomab is standard of care for children with relapsed acute lymphoblastic leukemia (ALL) and in de novo pediatric ALL for those who cannot tolerate or are resistant to conventional chemotherapy.
Advanced centres will be able to provide blinatumomab starting in the fall.
This session provided information on how to prepare and administer the drug and any other information required.